scorpion antivenom, whole igg (goat)
Animal productapproved
Approved
Jul 1, 1965
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jun 15, 2024 (NCT06333834)
Timeline
1960s
- Jul 1, 1965
Earliest FDA Approval
2020s
- Jan 1, 2024
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- scorpion toxinImmunity, passive
scorpion toxin immunity, passive
Approval history
- approvedJul 1, 1965
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- scorpion antivenom, whole igg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06333834 | Phase 2/Phase 3 (Phase 3) | Jun 15, 2024 | University of Guadalajara |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Guadalajara | Academic/Hospital | 1 | 1 | 1 | 2024 |
1 organizations
Page 1 / 1